Evidence map›Paper›PMID 23638075›Full record

ArticlePloS one2013

Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized.

Kejing Song, R Ranney Mize, Luis Marrero, Miriam Corti, Jason M Kirk, Seth H Pincus

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Recent advances in the development of vaccines against ricin.Human vaccines & immunotherapeutics · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kejing SongResearch Institute for Children, Children's Hospital, New Orleans, Louisiana, United States of America.
R Ranney Mize
Luis Marrero
Miriam Corti
Jason M Kirk
Seth H Pincus
Children's Hospital of New Orleans · USLouisiana State University Health Sciences Center New Orleans · USCarl Zeiss (United States) · US

Funding

Mechanisms of Antibody-Mediated Toxin NeutralizationR01AI059376 · NIAID · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI PINCUS, SETH H. · 2004 to 2008
$1.9M
NIAID NIH HHS AI 059376NIAID NIH HHS R01 AI059376
6 · The paper itself

Abstract

backgroundMechanisms of antibody-mediated neutralization are of much interest. For plant and bacterial A-B toxins, A chain mediates toxicity and B chain binds target cells. It is generally accepted and taught that antibody (Ab) neutralizes by preventing toxin binding to cells. Yet for some toxins, ricin included, anti-A chain Abs afford greater protection than anti-B. The mechanism(s) whereby Abs to the A chain neutralize toxins are not understood. METHODOLOGY/PRINCIPAL

findingsWe use quantitative confocal imaging, neutralization assays, and other techniques to study how anti-A chain Abs function to protect cells. Without Ab, ricin enters cells and penetrates to the endoplasmic reticulum within 15 min. Within 45-60 min, ricin entering and being expelled from cells reaches equilibrium. These results are consistent with previous observations, and support the validity of our novel methodology. The addition of neutralizing Ab causes ricin accumulation at the cell surface, delays internalization, and postpones retrograde transport of ricin. Ab binds ricin for >6hr as they traffic together through the cell. Ab protects cells even when administered hours after exposure. CONCLUSIONS/KEY

findingsWe demonstrate the dynamic nature of the interaction between the host cell and toxin, and how Ab can alter the balance in favor of the cell. Ab blocks ricin's entry into cells, hinders its intracellular routing, and can protect even after ricin is present in the target organelle, providing evidence that the major site of neutralization is intracellular. These data add toxins to the list of pathogenic agents that can be neutralized intracellularly and explain the in vivo efficacy of delayed administration of anti-toxin Abs. The results encourage the use of post-exposure passive Ab therapy, and show the importance of the A chain as a target of Abs.

Indexed as

Antibodies, MonoclonalAntibodies, NeutralizingAntigen-Antibody ComplexCell LineCell MembraneEndoplasmic ReticulumHumansIntracellular SpaceMicroscopy, ConfocalProtein BindingProtein TransportRicinTime FactorsToxins, BiologicalAntibodies, MonoclonalAntibodies, NeutralizingAntigen-Antibody ComplexRicinToxins, Biological

Identifiers

PMID23638075
PMCPMC3634765
OpenAlexW1994464548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.